ICM Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

ICM Asset Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$26K	Hold	21,500	–	–	0.14%	28
2020 Q2	$25K	Sell	21,500 -231,400	-91%	-$214K	0.13%	31
2020 Q1	$207K	Hold	252,900	–	–	0.2%	28
2019 Q4	$255K	Hold	252,900	–	–	0.21%	32
2019 Q3	$357K	Sell	252,900 -6,000	-2%	-$8.47K	0.28%	30
2019 Q2	$388K	Hold	258,900	–	–	0.29%	32
2019 Q1	$396K	Hold	258,900	–	–	0.3%	34
2018 Q4	$381K	Sell	258,900 -4,000	-2%	-$6.13K	0.34%	37
2018 Q3	$481K	Buy	262,900 +12,900	+5%	+$25K	0.34%	42
2018 Q2	$460K	Buy	+250,000	New	+$465K	0.4%	41

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ICM Asset Management's MBII Position: Q3 2020 in Review

ICM Asset Management held its Marrone Bio Innovations, Inc. (MBII) position steady in Q3 2020 at 21,500 shares worth $26K. The position accounts for 0.14% of the portfolio, ranked #28.

ICM Asset Management first reported a position in MBII in Q2 2018 and has held it in 10 quarters since. The position peaked at $481K in Q3 2018. 58 funds tracked by Wall St. Rank hold MBII as of Q3 2020.

ICM Asset Management held 21,500 shares of Marrone Bio Innovations, Inc. worth $26K as of Q3 2020.
ICM Asset Management left its Marrone Bio Innovations, Inc. share count unchanged in Q3 2020.
Marrone Bio Innovations, Inc. made up 0.14% of ICM Asset Management's portfolio in Q3 2020, its #28 holding.
ICM Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2018 and has held it in 10 quarters since.
ICM Asset Management's Marrone Bio Innovations, Inc. position peaked at $481K in Q3 2018.
58 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2020.

Based on ICM Asset Management's 13F filing for Q3 2020, filed 22 Oct 2020.